Effects of Tamsulosin and Tolterodine on double J stent-related symptoms: A double-blind, randomized, placebo-controlled trial.

ABSTRACT:

Background

Ureteral double J stent are routinely applied for urologic patients although stent-related symptoms are common. Several attempts have been reported to minimize these symptoms.

Objective

To compare Tolterodine, Tamsulosin, and placebo effects on double J stent-related symptoms.

Material and method

In all, 125 patients (82 males and 43 females) with double J stent were randomly divided into three groups (group 1, n: 42, group2, n: 40 and group 3, n: 43). Each patient randomly received one pack of drug in different colors by a nurse unaware of the content to take Tamsulosin 0.4 mg before sleep (MODALUSINE), Tolterodine 2 mg twice a day or placebo once daily (capsules filled with starch): group 1 received placebo, group 2 Tamsulosin and group 3 Tolterodine for

SUBMITTER: Moradi M 

PROVIDER: S-EPMC5349560 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature